Integrated Filing — IndAS



General information about company

Scrip Code 532300
NSE Symbol WOCKPHARMA
MSEI Symbol NOTLISTED
ISIN INE049B01025
Name of company Wockhardt Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 03-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 03-11-2025   11:45:00
End date and time of board meeting 03-11-2025   14:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 78,200.00 1,52,000.00
Other income 2,100.00 4,100.00
Total income 80,300.00 1,56,100.00
2 Expenses
(a) Cost of materials consumed 15,900.00 32,700.00
(b) Purchases of stock-in-trade 12,900.00 26,900.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (5,500.00) (9,900.00)
(d) Employee benefit expense 18,600.00 35,700.00
(e) Finance costs 5,500.00 10,300.00
(f) Depreciation, depletion and amortisation expense 5,300.00 10,900.00
(f) Other Expenses
1 Exchange fluctuation loss, net (1,800.00) 1,100.00
2 Other expenses 20,300.00 40,500.00
Total other expenses 18,500.00 41,600.00
Total expenses 71,200.00 1,48,200.00
3 Total profit before exceptional items and tax 9,100.00 7,900.00
4 Exceptional items 0.00 (9,700.00)
5 Total profit before tax 9,100.00 (1,800.00)
6 Tax expense
7 Current tax 300.00 700.00
8 Deferred tax 600.00 100.00
9 Total tax expenses 900.00 800.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 8,200.00 (2,600.00)
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 8,200.00 (2,600.00)
17 Other comprehensive income net of taxes 9,300.00 24,100.00
18 Total Comprehensive Income for the period 17,500.00 21,500.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 7,800.00 (1,200.00)
Total profit or loss, attributable to non-controlling interests 400.00 (1,400.00)
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 16,300.00 21,200.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 1,200.00 300.00
21 Details of equity share capital
Paid-up equity share capital 8,100.00 8,100.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.81 -0.72
Diluted earnings (loss) per share from continuing operations 4.81 -0.72
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.81 -0.72
Diluted earnings (loss) per share from continuing and discontinued operations 4.81 -0.72
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to Consolidated Results Please refer to the Statement of Consolidated Audited Results for the quarter and year ended September 30, 2025 as attached to the Outcome of Board Meeting.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1,67,300.00
Capital work-in-progress 58,300.00
Investment property 0.00
Goodwill 99,500.00
Other intangible assets 16,000.00
Intangible assets under development 1,56,800.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets 5,100.00
Total non-current financial assets 5,100.00
Deferred tax assets (net) 49,500.00
Other non-current assets 20,300.00
Total non-current assets 5,72,800.00
2 Current assets
Inventories 86,600.00
Current financial asset
Current investments 69,600.00
Trade receivables, current 53,600.00
Cash and cash equivalents 17,700.00
Bank balance other than cash and cash equivalents 5,700.00
Loans, current 0.00
Other current financial assets 4,800.00
Total current financial assets 1,51,400.00
Current tax assets (net) 0.00
Other current assets 32,100.00
Total current assets 2,70,100.00
3 Non-current assets classified as held for sale 10,400.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 8,53,300.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 8,100.00
Other equity 4,48,600.00
Total equity attributable to owners of parent 4,56,700.00
Non controlling interest 30,900.00
Total equity 4,87,600.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,66,900.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 12,100.00
Total non-current financial liabilities 1,79,000.00
Provisions, non-current 2,900.00
Deferred tax liabilities (net) 3,700.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 6,500.00
Total non-current liabilities 1,92,100.00
Current liabilities
Current financial liabilities
Borrowings, current 65,400.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 5,400.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 53,300.00
Total Trade payable 58,700.00
Other current financial liabilities 27,500.00
Total current financial liabilities 1,51,600.00
Other current liabilities 18,200.00
Provisions, current 3,200.00
Current tax liabilities (Net) 600.00
Deferred government grants, Current 0.00
Total current liabilities 1,73,600.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 3,65,700.00
Total equity and liabilites 8,53,300.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Notes to Assets and Liabilities: Please refer to the Statement of Consolidated Audited Results for the quarter and year ended September30, 2025 as attached to the Outcome of Board Meeting. Notes to Cash Flow Statements: 1. For Notes to Cash flow statement, please refer Audited Results for the quarter and year ended September 30, 2025 as attached which is submitted under Outcome of Board Meeting uploaded today on Stock Exchange. 2. Other adjustments for non cash items consists of, Allowance Reversal of allowance for expected credit loss, doubtful advances and bad debts Rs.7 crore, Profit Loss on sale of fixed assets net Rs.14 crore, Profit on sale of investments Rs.9 crore, Liabilities no longer required written back Rs.2 crore. 3. Adjustments for unrealised foreign exchange losses and gain consists of Net foreign exchange fluctuation loss or gain, net Rs.15 crore. 4. Proceeds from issuance of Equiy share capital under ESOS amounting to Rs.1 crore. 7. Repayment of borrowing consists of Repayment of long term borrowings Rs.91 crore, Repayment of loan taken from Related Parties Long term Rs.32 crore. 8.Proceeds from borrowings consists of Short term borrowing (net) Rs.12, Loan from related party Rs.12 and Proceeds of term Loan Rs.550 crore 8. Other inflows outflows of cash consists of Finance cost paid Rs.96 crore. 9. Aggregated or segregated in accordance with the prescribed format and to the extent is the requirement of the accounting standard.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to Profit or Loss -(charge) / credit (consisting of re-measurement of net defined benefit (liability) / asset) (22.00) (45.00)
2 Items that will not be reclassified to Profit or Loss -(charge) / credit (consisting of re-measurement of net defined benefit (liability) / asset) 22.00 45.00
Total Amount of items that will not be reclassified to profit and loss 0.00 0.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to Profit or Loss - (charge) / credit (Consisting of Exchange differences on translating the financial statements of foreign operations) 9,300.00 24,100.00
Total Amount of items that will be reclassified to profit and loss 9,300.00 24,100.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 9,300.00 24,100.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax (1,800.00)
Adjustments for reconcile profit (loss)
Adjustments for finance costs 10,300.00
Adjustments for decrease (increase) in inventories (10,900.00)
Adjustments for decrease (increase) in trade receivables, current 5,200.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 4,500.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 0.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (6,800.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 20,600.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 1,500.00
Adjustments for dividend income 0.00
Adjustments for interest income 200.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (500.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (1,800.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 21,900.00
Net cash flows from (used in) operations 20,100.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,200.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 18,900.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1,400.00
Purchase of property, plant and equipment 7,000.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 12,700.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 200.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (23,600.00)
Net cash flows from (used in) investing activities (41,700.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 100.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 55,000.00
Repayments of borrowings 12,300.00
Payments of lease liabilities 3,500.00
Dividends paid 0.00
Interest paid 9,600.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 29,700.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 6,900.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 6,900.00
Cash and cash equivalents cash flow statement at beginning of period 10,800.00
Cash and cash equivalents cash flow statement at end of period 17,700.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K C and Associates LLP Yes 30-09-2026